Clinical Trial Update: ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center [Phase 4]

View source ↗

Summary

A phase 4 randomized multi-center trial evaluating ATG/PTCy in haploidentical peripheral blood stem cell transplantation for myeloid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Tumor

Drugs mentioned

• ATG/PTCy

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Myeloid Tumor | Phase 4 | Status: COMPLETED